Golden Gate Capital related stories
All articles and analysis
Side Letter: More bang; less buck?Side Letter's 2025 quizmasters revealed; could a volatile start to 2026 hint at another shaky year for private equity activity?; Korea's sovereign wealth fund spies opportunity overseas.
How PE and VC are helping build a children's hospital in TexasThe Children’s Medical Center Foundation is leaning into emerging managers and secondaries as it quickly ramps up its exposure, seeking to boost returns in order to hit its funding goals for the hospital project.
Side Letter: Yale's saleThe buyers have been identified in one of this year's most closely watched PE sales processes. Plus: Florida SBA on AI opportunities and our PEI 300 video. Here's today's brief, for our valued subscribers only.
Side Letter: Money in or money out?New data suggests NAV loans are rarely used to massage DPI. Plus: a $23 billion pension has tweaked its PE allocation to get ahead of potential liquidity challenges; and a Japanese buyout firm completes an MBO. Here's today's brief, for our valued subscribers only.
Side Letter: PE newcomersHappy New Year! Side Letter is kicking off 2024 with a list of interesting emerging managers, a profile of Texas Municipal's new PE-loving CIO, and deployment data from sovereign investors. Here's today's brief, for our valued subscribers only.
Meet the 'oldest GP stakes firm you've never heard of’Australia-listed Pacific Current Group made headlines this year after receiving a takeover bid from one of its own portfolio companies.
PEI 300 2020: Six firms making their markThe firms from across the PEI 300 that made the headlines this year.
Side Letter: MAC clauses and virtual meetings, Golden Gate's secondaries play, Actis's impactMACs may become the order of the day depending on how the coronavirus outbreak continues. LPs and GPs are also discovering the joy of video conferencing. Plus: a Golden Gate portfolio company is tapping the secondaries market and Actis has spelled out its impact credentials. Here’s today's brief, for our valued subscribers only.
Deep Dive: Ignoring private equity's critics is no longer an optionPrivate equity is failing to find its voice or properly engage with its detractors and the barrage of criticism won’t stop until it does.
How to prepare mid-market portfolios for a recessionLPs want to know mid-market GPs are picking and prepping businesses that will survive a recession